| Name | HCV-IN-39 |
|---|
| Description | HCV-IN-39 (Compound 18a) is a potent hepatitis C virus (HCV) nucleoside inhibitor with EC50 values of 0.644, 0.952 and 0.154 μM against GT1a, GT1b and GT1b CES1 replicons[1]. |
|---|---|
| Related Catalog | |
| Target |
EC50: 0.644 μM (GT1a), 0.952 μM (GT1b), 0.154 μM (GT1b CES1)[1] |
| References |
| Molecular Formula | C21H26BrClN3O9P |
|---|---|
| Molecular Weight | 610.78 |